These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22754776)

  • 1. IRF-1 is critical for IFNγ mediated immune surveillance.
    Ksienzyk A; Neumann B; Kröger A
    Oncoimmunology; 2012 Jul; 1(4):533-534. PubMed ID: 22754776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF-1 expression is essential for natural killer cells to suppress metastasis.
    Ksienzyk A; Neumann B; Nandakumar R; Finsterbusch K; Grashoff M; Zawatzky R; Bernhardt G; Hauser H; Kröger A
    Cancer Res; 2011 Oct; 71(20):6410-8. PubMed ID: 21900395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines.
    Aquino-López A; Senyukov VV; Vlasic Z; Kleinerman ES; Lee DA
    Front Immunol; 2017; 8():391. PubMed ID: 28428785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I down-regulation: tumour escape from immune surveillance? (review).
    Bubeník J
    Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.
    Luo XM; Ross AC
    J Biol Chem; 2005 Oct; 280(43):36228-36. PubMed ID: 16085646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
    Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
    Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.
    Liu J; Guan X; Ma X
    J Biol Chem; 2005 Jul; 280(26):24347-55. PubMed ID: 15860458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors.
    Egwuagu CE; Li W; Yu CR; Che Mei Lin M; Chan CC; Nakamura T; Chepelinsky AB
    Oncogene; 2006 Jun; 25(26):3670-9. PubMed ID: 16462767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered IFNgamma signaling and preserved susceptibility to activated natural killer cell-mediated lysis of BCR/ABL targets.
    Cebo C; Voutsadakis IA; Da Rocha S; Bourhis JH; Jalil A; Azzarone B; Turhan AG; Chelbi-Alix M; Chouaib S; Caignard A
    Cancer Res; 2005 Apr; 65(7):2914-20. PubMed ID: 15805294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFα suppresses IFNγ-induced MHC class II expression on retinal pigmented epithelial cells cultures.
    Makhoul M; Bruyns C; Edimo WE; Relvas LJ; Bazewicz M; Koch P; Caspers L; Willermain F
    Acta Ophthalmol; 2012 Feb; 90(1):e38-42. PubMed ID: 21957872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response.
    Yang MQ; Du Q; Varley PR; Goswami J; Liang Z; Wang R; Li H; Stolz DB; Geller DA
    Br J Cancer; 2018 Jan; 118(1):62-71. PubMed ID: 29112686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
    Nikodemova M; Watters JJ; Jackson SJ; Yang SK; Duncan ID
    J Biol Chem; 2007 May; 282(20):15208-16. PubMed ID: 17395590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
    Zhou F; Chen J; Zhao KN
    J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
    Carlsten M; Norell H; Bryceson YT; Poschke I; Schedvins K; Ljunggren HG; Kiessling R; Malmberg KJ
    J Immunol; 2009 Oct; 183(8):4921-30. PubMed ID: 19801517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1): observations in IRF-1 knockout mice.
    Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
    Transplantation; 1996 Dec; 62(12):1895-901. PubMed ID: 8990383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.